News UChicago Advances Cancer Research Through Partnership with AbbVie On campus and beyond, the University of Chicago community is constantly striving to innovate and drive discovery through research and development. In the field of oncology, there is no exception....
News Halo Awards Honor ‘Heroes Of Medicine’ and 40 Under 40 Chicago Scientists Many UChicago and Polsky-affiliated scientists and researchers were among the honorees.
News Patent of the Week: Precisely Delivering High Dose Radiation to Multiple Tumor Sites University of Chicago researchers have developed an algorithm and prototype software package that successfully generates radiation beam angles for more precisely delivering treatment to multiple tumor sites. Stereotactic ablative body...
News Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic University of Chicago spinout Onchilles Pharma plans to initiate first-in-human clinical trials next year for its lead drug candidate – which has demonstrated broad, potent, and direct tumor-killing activity. The...
News Life Sciences Community Convenes at Chicago BioCapital Summit in a Showcase of Local Innovation Hosted by the Chicago Biomedical Consortium (CBC), the inaugural Chicago BioCapital Summit this week brought together industry, academia, and investors in a showcase of the latest innovations in the life...
Page License Technologies technology Licensing Discover new solutions to expand your pipeline with breakthrough, validated technologies ready for commercialization. Technologies at the University of Chicago are available for licensing across several industries, from...
Technology A Spatially Resolved Intracellular Photoproximity Profiling Technology For Mapping And Targeting Protein Interactions In Cancer A matched pair of photoproximity probes coupled with quantitative proteomics which enable context-dependent mapping of protein complex topology inside cells including to map MYC interactomes across temporal, spatial and disease-relevant…
Technology Self-assembling Nanofibril Particles for Controlled Release of IV and SUBQ Therapeutics Clinically approved methods for the controlled release of oral therapies have demonstrated their efficacy in reducing required dosage, administration frequency, and side effects, thereby boosting patient compliance. Despite these successes,…
Technology Rad51 Inhibitors for Sensitization to Chemotherapy and Radiation Optimized small-molecule inhibitors of RAD51 that selectively suppress D-loop formation and homologous recombination The Unmet Need: Selective agents that suppress homologous recombination repair without off-target toxicity. RAD51 is a central…
Technology A Biomarker Analysis Platform For Predicting Immunotherapy Response And Survival In Cancer Patients A method using tumor sequencing data to measure membrane-localized neoantigens, helping predict which cancer patients will benefit from immunotherapy, even those with low tumor mutational burden, improving treatment selection and…
Technology Ligand-Directed Photo-Proximity Labeling Technology For Profiling And Detecting Cancer Biomarker Interactions In Live Cells Light-activated chemical probes to label and identify proteins near cancer biomarkers on live cells and tissues, enabling detailed study of protein interactions and signaling pathways relevant to cancer diagnosis and…
Technology Novel RAD51 Inhibitors For Homologous Recombination Suppression And Chemosensitization A cell-active RAD51 inhibitor scaffold with an optimized reversible analog that reduces reactivity liabilities and is well suited for research-use commercialization and further oncology lead optimization The Unmet Need: Selective,…
